https://pubmed.ncbi.nlm.nih.gov/38427724/?dopt=Abstract
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies
Cancers exploit coinhibitory receptors on T cells to escape tumor immunity, and targeting such mechanisms has shown remarkable clinical benefit, but in a...
t cellcheckpointpathway